Total Payments
$1,648
2024 Payments
$747.68
Companies
16
Transactions
109
Medicare Patients
4,989
Medicare Billing
$459,705
Payment Breakdown by Category
Food & Beverage$1,613 (97.9%)
Education$34.86 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,613 | 107 | 97.9% |
| Education | $34.86 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $581.75 | 39 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $367.02 | 30 | $0 (2024) |
| Ardelyx, Inc. | $184.31 | 10 | $0 (2024) |
| Celltrion USA Inc. | $100.24 | 5 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $61.81 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $51.66 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $46.65 | 3 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $46.36 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $45.48 | 3 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $37.29 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $747.68 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($207.80) |
| 2023 | $359.78 | 23 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($182.07) |
| 2022 | $438.30 | 36 | Takeda Pharmaceuticals U.S.A., Inc. ($168.37) |
| 2021 | $101.78 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($71.45) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Gastroenterology | ||||||
| 08/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 1,944 | 3,902 | $899,188 | $181,757 |
| 2022 | 3 | 1,884 | 3,258 | $749,964 | $166,137 |
| 2021 | 4 | 1,161 | 2,033 | $465,504 | $111,811 |
Total Patients
4,989
Total Services
9,193
Medicare Billing
$459,705
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,458 | 3,323 | $804,166 | $142,792 | 17.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 262 | 313 | $53,210 | $24,584 | 46.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 205 | 235 | $34,310 | $13,402 | 39.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 19 | 31 | $7,502 | $979.78 | 13.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,436 | 2,747 | $664,774 | $130,970 | 19.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 260 | 293 | $49,810 | $23,789 | 47.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 166 | 181 | $26,426 | $10,438 | 39.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 22 | 37 | $8,954 | $939.75 | 10.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 877 | 1,693 | $409,706 | $87,661 | 21.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 170 | 217 | $36,890 | $17,689 | 47.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 96 | 98 | $14,308 | $5,759 | 40.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 18 | 25 | $4,600 | $701.85 | 15.3% |
About Dr. Daniel Nevin, MD
Dr. Daniel Nevin, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013126416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Nevin, MD has received a total of $1,648 in payments from pharmaceutical and medical device companies, with $747.68 received in 2024. These payments were reported across 109 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,613).
As a Medicare-enrolled provider, Nevin has provided services to 4,989 Medicare beneficiaries, totaling 9,193 services with total Medicare billing of $459,705. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Irving, TX
- Active Since 05/22/2007
- Last Updated 03/28/2018
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1013126416
Products in Payments
- XIFAXAN (Drug) $444.65
- ENTYVIO (Biological) $367.02
- IBSRELA (Drug) $184.31
- TRULANCE (Drug) $137.10
- ZENPEP (Drug) $99.10
- DUPIXENT (Biological) $80.34
- VEGZELMA (Biological) $65.38
- OCALIVA (Drug) $46.36
- VOQUEZNA (Drug) $45.48
- ZYMFENTRA (Biological) $34.86
- SUTAB (Drug) $29.24
- REMICADE (Biological) $27.46
- RESMETIROM (Drug) $22.50
- TREMFYA (Drug) $19.19
- REBYOTA (Biological) $16.12
- IQIRVO (Drug) $15.62
- Talicia (Drug) $12.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Irving
Robert Genta, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $73,890
Anatomic Pathology & Clinical Pathology $73,890
Dr. Reenu Malhotra, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $340.59
Anatomic Pathology & Clinical Pathology $340.59
Robert Wells, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $268.96
Anatomic Pathology & Clinical Pathology $268.96
Dr. Sharlene Batiste-Milton, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $197.24
Anatomic Pathology & Clinical Pathology $197.24
Dr. Richard Hare, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $146.76
Anatomic Pathology & Clinical Pathology $146.76
Dr. Keith Aldred, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $131.50
Anatomic Pathology & Clinical Pathology $131.50